74 related articles for article (PubMed ID: 22541576)
21. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
22. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
[TBL] [Abstract][Full Text] [Related]
23. Why do we go on screening?
Marsan C
Pol J Pathol; 2005; 56(4):167-9. PubMed ID: 16477875
[TBL] [Abstract][Full Text] [Related]
24. [Human papillomavirus testing. Important to differ between screening and diagnostics].
Fomsgaard A
Ugeskr Laeger; 2002 Mar; 164(13):1831; author reply 1831. PubMed ID: 11957447
[No Abstract] [Full Text] [Related]
25. [Is the HPV test to supplement vaginal smears in menopausal women?].
Gustavsson I; Gyllensten U; Lindell M; Wilander E
Lakartidningen; 2010 Feb 24-Mar 2; 107(8):528-9. PubMed ID: 20384066
[No Abstract] [Full Text] [Related]
26. Colposcopy, cervical screening, and HPV. Preface.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
[No Abstract] [Full Text] [Related]
27. Human papillomavirus: emerging trends in detection and management.
Wright JD; Herzog TJ
Curr Womens Health Rep; 2002 Aug; 2(4):259-65. PubMed ID: 12150752
[TBL] [Abstract][Full Text] [Related]
28. Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
Ogilvie G; Nakisige C; Huh WK; Mehrotra R; Franco EL; Jeronimo J
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():15-19. PubMed ID: 28691338
[TBL] [Abstract][Full Text] [Related]
29. [Medicine and money: detection of HPV DNA--what's the impediment?].
Miseta A
Orv Hetil; 2003 Dec; 144(52):2589-90. PubMed ID: 15005070
[No Abstract] [Full Text] [Related]
30. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
31. Acceptability of self-collection of specimens for HPV DNA testing in an urban population.
Anhang R; Nelson JA; Telerant R; Chiasson MA; Wright TC
J Womens Health (Larchmt); 2005 Oct; 14(8):721-8. PubMed ID: 16232104
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
Wright TC
Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
[TBL] [Abstract][Full Text] [Related]
33. HPV: from the cervical smear to the research bench to the court room.
Atkins K
Clin Leadersh Manag Rev; 2003; 17(6):341-5. PubMed ID: 14692078
[TBL] [Abstract][Full Text] [Related]
34. [HPV-tests as suitable complement to cytological screening].
Rubinstein E
Lakartidningen; 1999 May; 96(18):2195. PubMed ID: 10377654
[No Abstract] [Full Text] [Related]
35. HPV test: antidote to ASCUS headache?
Titus K
CAP Today; 1996 Sep; 10(9):1, 52-4, 56-8. PubMed ID: 10166422
[No Abstract] [Full Text] [Related]
36. HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis.
Kmietowicz Z
BMJ; 2013 Nov; 347():f6624. PubMed ID: 24191217
[No Abstract] [Full Text] [Related]
37. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
[TBL] [Abstract][Full Text] [Related]
38. Human papilloma virus: diagnostic, treatment and preventive issues.
Christopoulos P; Deligeoroglou E; Papadias K; Creatsas G
Akush Ginekol (Sofiia); 2008; 47(1):35-8. PubMed ID: 18642576
[TBL] [Abstract][Full Text] [Related]
39. Testing for human papillomavirus in women with abnormal pap smear results.
McCaffery KJ; Waller J; Forrest S; Wardle J
JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
[No Abstract] [Full Text] [Related]
40. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
